changing from semaglutide to mounjaro Switching Wegovy Switching from Ozempic to Mounjaro

Food and Drug Administration approved the semaglutide injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity

Retatrutide is producing larger losses, faster

Both compounds have established safety profiles with predictable side effect patterns

By mimicking natural hormones, it can help patients feel satisfied with smaller meals, making it easier to maintain a balanced diet

Wegovy is a GLP-1 weight loss medication and it is unlikely to cause diverticulitis